Current Report Filing (8-k)
January 30 2018 - 5:02PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 30, 2018
MEDICAL
INNOVATION HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
Colorado
|
|
000-27211
|
|
84-1469319
|
(State
or Other Jurisdiction
of Incorporation)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification No.)
|
5805
State Bridge Road, Suite G-328, Duluth, Georgia 30097
(Address
of Principal Executive Offices) (Zip Code)
(866)
883-3793
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
SECTION
1 — REGISTRANT’S BUSINESS AND OPERATIONS
ITEM
1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On
January 30, 2018 Medical Innovation Holdings, Inc. (“MIHI”), a Colorado corporation (the “Company”) entered
into a Memorandum of Understanding (MOU) with Advanced Medical Pricing Solutions (AMPS). Medical Innovation Holdings, Inc. and
Advanced Medical Pricing Solutions are to provide collaborative services in developing and bringing solutions to the market that
can potentially expand the use of telemedicine, as an outreach /access tool and as a cost containment tool.
The
above description of the Letter of Intent is intended as a summary only and is qualified in its entirety by the terms and conditions
set forth therein, and may not contain all information that is of interest to the reader. For further information regarding the
terms and conditions of the Memorandum of Understanding, this reference is made to the Memorandum of Understanding, which is filed
hereto as Exhibit 10.1 and is incorporated herein by this reference.
SECTION
9 — FINANCIAL STATEMENTS AND EXHIBITS
ITEM
9.01 FINANCIAL STATEMENTS AND EXHIBITS
The
following is a complete list of exhibits filed as part of this Report.
Exhibit
numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
Medical
Innovation Holdings, Inc.
|
|
|
|
By
|
/s/
Arturo Jake Sanchez
|
|
Name:
|
Arturo
“Jake” Sanchez
|
|
Title:
|
CEO
|
Date:
January 30, 2018